GC녹십자 그룹 내 세포·유전자치료제 전문 개발사 지씨셀(GC Cell)의 R&D pipeline, 연구개발, CDMO, 상업화/유통 역량 소개
近日,GC Cell宣布与Checkpoint Therapeutics(以下简称“Checkpoint”)达成战略合作,共同探索Checkpoint公司的cosibelimab(抗PD-L1抗体)与GC Cell的Immuncell-LC(自体T细胞疗法)进行联合治疗的潜力。 新闻稿指出,此次合作将首先在体外进行联合研究,以评...
GC Cell的价格 / 最近12个月的自由现金流于December 2019触及5年低点,是-65.5x。 GC Cell的价格 / 最近12个月的自由现金流于2021 (106.8x, -89.3%)和2022 (14.6x, -86.4%)减少和于2020 (1,000.8x, -1,627.0%)和2023 (175.1x, +1,102.0%)增加。
GC Cell上季度的 营运资本净额为31.695十亿。 Décembre 2019至2023的财年GC Cell的营运资本净额为 10.077十亿 Décembre 2019至 2023的财年,GC Cell的营运资本净额中值为2.48十亿。 过去5年,GC Cell的营运资本净额在septembre 2024达到了 31.695十亿的峰值。 GC Cell的营运资本净额于décembre 2020触及5年低点,是-1.5...
“As the first-ever overseas event for a cell therapy created in Korea, this symposium marks is a significant milestone for the industry,” said a GC Cell spokesperson. “By building trust and visibility in the Indonesian market, we are accelerating the global commercialization of Imm...
GC Cell, a fully integrated cell and gene therapy pioneer, is proud to announce the establishment of an MOU for strategic partnership with Bifarma, a frontrunner in stem cell therapy within Indonesia with comprehensive capabilities in R&D, GMP-compliant
检查站,GC Cell评估联合癌症疗法 Checkpoint Therapeutics(CKPT) stem(STEM)0.4422-8.41% Checkpoint Therapeutics (NASDAQ:CKPT) and South Korea's GC Cell will collaborate on a combination treatment of the former's cosibelimab, an anti-PD-L1 antibody, and the latter's Immuncell-LC, a T-cell ...
Checkpoint Therapeutics (NASDAQ:CKPT) and South Korea's GC Cell will collaborate on a combination treatment of the former's cosibelimab, an anti-PD-L1 antibody, and the latter's Immuncell-LC, a T-cell therapy. At the outset, the work will focus on in vitro studies to examine synergistic...
Alternative Names:Autoimmune disease therapy - GC Cell; Dendritic cell therapy - GC Cell; Regulatory T cell therapy - GC Cell; Stem cell therapy - GC Cell Latest Information Update:12 Sep 2019 Price : €55* Note: Adis is an information provider.We do not sell or distribute actual drugs. ...
上海玉博生物科技有限公司 主要致力于“GC CELL LYSATE 500UG ”的生产销售。多年的“GC CELL LYSATE 500UG ”生产与销售的经验,与各行业新老用户建立了稳定的合作关系,我公司经营的产品名称深受广大用户信赖。欢迎来电咨询或前来选购